Phase 1 Dose Escalation of ArtemiCoffee
Clinical trial NCT04805333 · COMPLETED
Trial details
- NCT number
- NCT04805333
- Sponsor
- Frederick R. Ueland, M.D.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2025-02-04
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.